Pharmatory has completed the first renovation and investment round during the annual maintenance break in July 2024.

The project included expansion of the QC laboratory and renovation of the current laboratory space to better serve the current needs of the company. In addition, the warehouse and raw material reception area were completely renovated. A new 160-liter Buchi reactor has been installed in the largest pilot room, bringing more flexibility and efficiency to production of tens of kilograms of final products. The company also expects to triple its cGMP manufacturing kg-capacity by the end of 2025 to meet the future customer needs. Regarding this phase II investment round, the great news is that next year there will be also an opportunity to expand office and meeting room space within the same building.
The investment project is partly funded by an EURA grant.